The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A CRISPR-edited allogeneic anti-CD19 CAR-T cell therapy with a PD-1 knockout (CB-010) in patients with relapsed/refractory B cell non-Hodgkin lymphoma (r/r B-NHL): Updated phase 1 results from the ANTLER trial.
 
Boyu Hu
Honoraria - Guidepoint Inc
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb/Celgene; Caribou Biosciences; Genmab; ImmPACT Bio; Lilly; Novartis; Regeneron; Seagen
Speakers' Bureau - Binacea; Curio Science; OncLive/MJH Life Sciences; Patient Power; Total Health Conferencing
Research Funding - Artiva (Inst); AstraZeneca (Inst); Caribou Biosciences (Inst); Celgene (Inst); crispr therapeutics (Inst); ImmPACT Bio (Inst); MorphoSys/Incyte (Inst); Newave Pharmaceutical (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - DAVA Oncology
 
Loretta J. Nastoupil
Honoraria - ADC Therapeutics; AstraZeneca; Bristol-Myers Squibb; Caribou Biosciences; Daiichi Sankyo/UCB Japan; Epizyme; Genentech/Roche; Genmab; Gilead Sciences; Incyte; Ipsen; Janssen Oncology; Morphosys; Novartis; Takeda
Consulting or Advisory Role - Interius Biotherapeutics; SIRPant Immunotherapeutics
Research Funding - Allogene Therapeutics; Bristol-Myers Squibb/Celgene; Caribou Biosciences; Daiichi Sankyo/UCB Japan; Daiichi Sankyo/UCB Japan; Epizyme; Genentech/Roche; Genmab; Gilead Sciences; IgM Biosciences; Ipsen; Janssen Biotech; Novartis; Takeda
Travel, Accommodations, Expenses - Genentech/Roche
 
Houston Holmes
Leadership - Exuma Biotech
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb/Celgene/Juno; Celgene; crispr therapeutics; Epizyme; Genentech; Janssen; Karyopharm Therapeutics; Kite/Gilead; Rigel; TG Therapeutics
Speakers' Bureau - Dova Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Rigel; Seagen
Research Funding - ADC Therapeutics (Inst); Adicet Bio (Inst); Allogene Therapeutics (Inst); Artiva (Inst); Autolus (Inst); Bristol-Myers Squibb/Celgene (Inst); Caribou Biosciences (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Janssen (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); MorphoSys (Inst); Novartis (Inst); Precision Biosciences (Inst); Viracta Therapeutics (Inst)
 
Ayad Hamdan
No Relationships to Disclose
 
Abraham Kanate
Stock and Other Ownership Interests - Iovance Biotherapeutics
Speakers' Bureau - Kite, a Gilead company
 
Umar Farooq
Honoraria - Caribou Biosciences; Kite, a Gilead company; Morphosys
Research Funding - Checkmate Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Mohamad Cherry
Honoraria - Epizyme; Genentech
Consulting or Advisory Role - Genentech; Pharmacosmos
Speakers' Bureau - Bms; Sanofi; Secura bio
 
Elizabeth Brem
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Celgene; Celgene; Genentech; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; MorphoSys; Pfizer; Pharmacyclics; Sanofi; TG Therapeutics
Speakers' Bureau - AstraZeneca; BeiGene; Celgene; MorphoSys; Pharmacyclics; Seagen
Research Funding - AstraZeneca; Genmab; Kowa Pharmaceutical; Viracta Therapeutics
 
Lauren C. Pinter-Brown
Consulting or Advisory Role - Kyowa Hakkko Kirin; Secura Bio
 
Daniel Arthur Ermann
Stock and Other Ownership Interests - Pfizer; Roche
 
Muhammad Husnain
Consulting or Advisory Role - Caribou Biosciences
 
Kenneth Micklethwaite
No Relationships to Disclose
 
Syed Rizvi
Employment - Caribou Biosciences
Leadership - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
 
Ashley Hammad
Employment - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
 
Ben Thompson
Employment - Caribou Biosciences
 
Enrique Zudaire
Employment - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
Honoraria - Caribou Biosciences
Research Funding - Caribou Biosciences
Patents, Royalties, Other Intellectual Property - Caribou Biosciences
Travel, Accommodations, Expenses - Caribou Biosciences
Other Relationship - Caribou Biosciences
 
Socorro Portella
Employment - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences; Novartis
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Caribou Biosciences; crispr therapeutics; Gamida Cell; Genentech; Genmab; Incyte; Kite/Gilead; MorphoSys; Myeloid Therapeutics; Novartis; Omeros; Puma Biotechnology (I); Sanofi; Seagen; Verastem
Speakers' Bureau - ADC Therapeutics; AstraZeneca; BeiGene; Genzyme; Kite/Gilead
Research Funding - Astellas Pharma; Genzyme; Genzyme; Otsuka; Spectrum Pharmaceuticals; Takeda
 
James Essell
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Genmab; Kite, a Gilead Company
Travel, Accommodations, Expenses - Caribou Biosciences
 
Susan Mary O'Brien
Employment - University of California, Irvine
Honoraria - Abbvie; Amgen; Caribou Biosciences; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Pfizer; Pharmacyclics; Secura Bio; TG Therapeutics; Vaniam Group
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Caribou Biosciences; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Pfizer; Pharmacyclics; Secura Bio; TG Therapeutics; Vaniam Group
Research Funding - Caribou Biosciences (Inst); MustangBio (Inst); Nurix (Inst); Pharmacyclics (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Abbvie/Genentech; Celgene; Gilead Sciences; Janssen; Janssen Oncology; Regeneron